USD 83.1
(0.0%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Operating Cash Flow | 12.3 Million | 12.19 Million | 8.99 Million | 7.79 Million | 7.7 Million |
Net Income | 11.04 Million | 9.86 Million | 8.02 Million | 5.5 Million | 5.48 Million |
Depreciation & Amortization | 963 Thousand | 1.26 Million | 1.36 Million | 1.36 Million | 1.25 Million |
Deferred income taxes | -331 Thousand | -58 Thousand | 417 Thousand | -743 Thousand | -466 Thousand |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -1.36 Million | -1.06 Million | -2.04 Million | -852 Thousand | 394 Thousand |
Other non-cash items | 3.91 Million | 4.71 Million | 2.6 Million | 3.88 Million | 2.29 Million |
Investing Cash Flow | -60.51 Million | -121.57 Million | -72.05 Million | -57.96 Million | -10.22 Million |
Investments in PPE | -183 Thousand | -910 Thousand | -622 Thousand | -1.01 Million | -602 Thousand |
Acquisitions | 137 Thousand | - | 250 Thousand | 4.3 Million | 47 Thousand |
Investment purchases | -15.85 Million | -51.07 Million | -72.82 Million | -53.68 Million | -27.77 Million |
Sales/Maturities of investments | 33.12 Million | 14.32 Million | 22.19 Million | 23.71 Million | 31.49 Million |
Other Investing Activities | -77.74 Million | 430 Thousand | -21.05 Million | -215 Thousand | -13.38 Million |
Financing Cash Flow | 542 Thousand | 46.78 Million | 111.01 Million | 157.83 Million | 20.79 Million |
Debt repayment | - | -10 Million | - | - | -10 Million |
Dividends payments | -2.52 Million | -2.46 Million | -2.43 Million | -2.39 Million | -2.36 Million |
Common Stock Repurchased | -196 Thousand | - | - | - | -240 Thousand |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | 3.26 Million | 49.25 Million | 113.44 Million | 160.23 Million | 23.39 Million |
Accounts receivables | - | - | - | - | - |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | -1.36 Million | - | - | - | - |
Cash at beginning of period | - | 204.41 Million | 156.45 Million | 48.78 Million | 30.51 Million |
Cash at end of period | -47.66 Million | 141.82 Million | 204.41 Million | 156.45 Million | 48.78 Million |
Capital Expenditure | -183 Thousand | -910 Thousand | -622 Thousand | -1.01 Million | -602 Thousand |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -47.66 Million | -62.59 Million | 47.96 Million | 107.66 Million | 18.27 Million |
Free Cash Flow | 12.12 Million | 11.28 Million | 8.37 Million | 6.77 Million | 7.1 Million |
Breakdown | 2023 FY | 2022 FY | 2021 FY | 2020 FY | 2019 FY |
---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - |
Net Income | 11.04 Million | 9.86 Million | 8.02 Million | 5.5 Million | 5.48 Million |
Depreciation & Amortization | 963 Thousand | 1.26 Million | 1.36 Million | 1.36 Million | 1.25 Million |
Deferred income taxes | -331 Thousand | -58 Thousand | 417 Thousand | -743 Thousand | -466 Thousand |
Stock-based compensation | - | - | - | - | - |
Change in working capital | -1.36 Million | -1.06 Million | -2.04 Million | -852 Thousand | 394 Thousand |
Other non-cash items | 3.91 Million | 4.71 Million | 2.6 Million | 3.88 Million | 2.29 Million |
Investing Cash Flow | -60.51 Million | -121.57 Million | -72.05 Million | -57.96 Million | -10.22 Million |
Investments in PPE | -183 Thousand | -910 Thousand | -622 Thousand | -1.01 Million | -602 Thousand |
Acquisitions | 137 Thousand | - | 250 Thousand | 4.3 Million | 47 Thousand |
Investment purchases | -15.85 Million | -51.07 Million | -72.82 Million | -53.68 Million | -27.77 Million |
Sales/Maturities of investments | 33.12 Million | 14.32 Million | 22.19 Million | 23.71 Million | 31.49 Million |
Other Investing Activities | - | 430 Thousand | -21.05 Million | -215 Thousand | -13.38 Million |
Financing Cash Flow | 542 Thousand | 46.78 Million | 111.01 Million | 157.83 Million | 20.79 Million |
Debt repayment | - | -10 Million | - | - | -10 Million |
Dividends payments | -2.52 Million | -2.46 Million | -2.43 Million | -2.39 Million | -2.36 Million |
Common Stock Repurchased | -196 Thousand | - | - | - | -240 Thousand |
Common Stock Issuance | - | - | - | - | - |
Other Financing Activities | - | 49.25 Million | 113.44 Million | 160.23 Million | 23.39 Million |
Accounts receivables | - | - | - | - | - |
Accounts payables | - | - | - | - | - |
Inventory | - | - | - | - | - |
Other working capital | - | - | - | - | - |
Cash at beginning of period | - | 204.41 Million | 156.45 Million | 48.78 Million | 30.51 Million |
Cash at end of period | -47.66 Million | 141.82 Million | 204.41 Million | 156.45 Million | 48.78 Million |
Capital Expenditure | -183 Thousand | -910 Thousand | -622 Thousand | -1.01 Million | -602 Thousand |
Effect of forex changes on cash | - | - | - | - | - |
Net cash flow / Change in cash | -47.66 Million | -62.59 Million | 47.96 Million | 107.66 Million | 18.27 Million |
Free Cash Flow | 12.12 Million | 11.28 Million | 8.37 Million | 6.77 Million | 7.1 Million |
7235
ALCYB
VEXTF
600458
1439
MURGY